Markers of oxidative stress and erythrocyte antioxidant enzyme activity in older men and women with differing physical activity

2013 ◽  
Vol 48 (11) ◽  
pp. 1141-1146 ◽  
Author(s):  
Rafał Rowiński ◽  
Mariusz Kozakiewicz ◽  
Kornelia Kędziora-Kornatowska ◽  
Elżbieta Hübner-Woźniak ◽  
Józef Kędziora
2007 ◽  
Vol 32 (4) ◽  
pp. 677-685 ◽  
Author(s):  
Cecilia M. Shing ◽  
Jonathan M. Peake ◽  
Shannon M. Ahern ◽  
Natalie A. Strobel ◽  
Gary Wilson ◽  
...  

We examined the influence of 3 consecutive days of high-intensity cycling on blood and urinary markers of oxidative stress. Eight highly-trained male cyclists (VO2 max76 ± 4 mL·kg–1·min–1; mean ± SD) completed an interval session (9 exercise bouts lasting 30 s each, at 150% peak power output) on day 1, followed by 2 laboratory-simulated 30 km time trials on days 2 and 3. The cyclists also completed a submaximal exercise trial matched to the interval session for oxygen consumption. Blood was collected pre- and post-exercise for the determination of malondialdehyde (MDA), total antioxidant status (TAS), vitamin E, and the antioxidant enzyme activity of superoxide dismutase and glutathione peroxidase, while urine was collected for the determination of allantoin. There were significant increases in plasma MDA concentrations (p < 0.01), plasma TAS (p < 0.01), and urinary allantoin excretion (p < 0.01) following the high-intensity interval session on day 1, whereas plasma vitamin E concentration significantly decreased (p = 0.028). Post-exercise changes in plasma MDA (p = 0.036), TAS concentrations (p = 0.039), and urinary allantoin excretion (p = 0.031) were all significantly attenuated over the 3 consecutive days of exercise, whereas resting plasma TAS concentration was elevated. There were no significant changes in plasma MDA, TAS, or allantoin excretion following submaximal exercise and there were no significant changes in antioxidant enzyme activity over consecutive days of exercise or following submaximal exercise. Consecutive days of high-intensity exercise enhanced resting plasma TAS concentration and reduced the post-exercise increase in plasma MDA concentrations.


2018 ◽  
Vol 23 (6) ◽  
pp. 1319-1327 ◽  
Author(s):  
Eliara Ten Caten Martins ◽  
Rafaella Zulianello dos Santos ◽  
Analu Bender dos Santos ◽  
Pauline Brendler Goettems Fiorin ◽  
Yana Picinin Sandri ◽  
...  

2020 ◽  
Vol 30 (8) ◽  
pp. 1409-1422 ◽  
Author(s):  
Sari Aaltonen ◽  
Katja Waller ◽  
Henri Vähä‐Ypyä ◽  
Juha Rinne ◽  
Harri Sievänen ◽  
...  

2009 ◽  
Vol 139 (10) ◽  
pp. 1896-1900 ◽  
Author(s):  
Tinna Traustadóttir ◽  
Sean S. Davies ◽  
Anthoney A. Stock ◽  
Yali Su ◽  
Christopher B. Heward ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. 153473541987281 ◽  
Author(s):  
Irida Dhima ◽  
Stelios Zerikiotis ◽  
Panagiotis Lekkas ◽  
Yannis V. Simos ◽  
Maria Gkiouli ◽  
...  

Background. Cisplatin (cis-diamminedichloroplatinum) is a widely used chemotherapeutic agent for the treatment of various cancers. Although it represents an effective regimen, its application is accompanied by side effects to normal tissues, especially to the kidneys. Cisplatin generates free radicals and impairs the function of antioxidant enzymes. Modulation of cisplatin-induced oxidative stress by specific antioxidant molecules represents an attractive approach to minimize side effects. Methods. We studied the ability of curcumin to sensitize leiomyosarcoma (LMS) cells to cisplatin. Assays for cell proliferation, mitochondrial function, induction of apoptosis, and cell cycle arrest were performed using various concentrations of cisplatin and a concentration of curcumin that caused a nonsignificant reduction in cell viability. Moreover, the effect of curcumin was examined against cisplatin-induced experimental nephrotoxicity. Renal injury was assessed by measuring serum creatinine, blood urea nitrogen (BUN), and the kidney’s relative weight. Oxidative stress was measured by means of enzymatic activities of superoxide dismutase and glutathione peroxidase in the rats’ blood and malondialdehyde levels in rats’ urine. Results. In our study, we found that curcumin sensitizes LMS cells to cisplatin by enhancing apoptosis and impairing mitochondrial function. In an in vivo model of cisplatin-induced experimental nephrotoxicity, intraperitoneal administration of curcumin failed to preserve blood’s antioxidant enzyme activity and decrease lipid peroxidation. Nevertheless, curcumin was able to protect nephrons’ histology from cisplatin’s toxic effect. Conclusion. Our results showed that curcumin can act as chemosensitizer, but its role as an adjunctive cisplatin-induced oxidative stress inhibitor requires further dose-finding studies to maximize the effectiveness of chemotherapy.


2002 ◽  
Vol 76 (2) ◽  
pp. 473-481 ◽  
Author(s):  
Virginia A Hughes ◽  
Walter R Frontera ◽  
Ronenn Roubenoff ◽  
William J Evans ◽  
Maria A Fiatarone Singh

2014 ◽  
Vol 99 (1) ◽  
pp. E149-E152 ◽  
Author(s):  
Bess Dawson-Hughes ◽  
Susan S. Harris ◽  
Lisa Ceglia ◽  
Nancy J. Palermo

Context: To establish the clinical utility of serum sclerostin levels, it is important to know whether there is seasonal variation in the measurements. Objective: This study was done to determine whether serum sclerostin levels vary by season in healthy older men and women. Methods: Serum sclerostin levels were measured in archived serum of 314 healthy men and women aged 65 years and older and examined for seasonal variation. Several factors known to vary by season and previously reported to be associated with serum sclerostin levels, including serum osteocalcin, physical activity, and serum PTH levels, were also measured in these subjects. Sex did not modify the association of season with sclerostin, so the men and women were analyzed together. Results: Serum sclerostin levels varied significantly by season (P &lt; .001, after adjustment for sex). Sclerostin levels in the wintertime were 20% higher than the all-year mean, the levels gradually declined through the spring and summer, and by the fall, they were 20% below the all-year mean. Adjustment for serum osteocalcin, physical activity, and serum PTH did not alter the seasonal means. Seasonal differences in serum osteocalcin, physical activity, and serum PTH were not statistically significant. Conclusions: This study documents marked seasonal variation in serum sclerostin levels. It is important to recognize this source of biological variability when considering the potential clinical utility of sclerostin measurements.


Sign in / Sign up

Export Citation Format

Share Document